These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 10505629)
1. Metallothionein-I and -II knock-out mice are not more sensitive than control mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. Rojas P; Klaassen CD Neurosci Lett; 1999 Oct; 273(2):113-6. PubMed ID: 10505629 [TBL] [Abstract][Full Text] [Related]
3. Metallothionein inducers protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice. Rojas P; Ríos C Neurochem Res; 1997 Jan; 22(1):17-22. PubMed ID: 9021756 [TBL] [Abstract][Full Text] [Related]
4. Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide. Cosi C; Marien M Brain Res; 1998 Oct; 809(1):58-67. PubMed ID: 9795136 [TBL] [Abstract][Full Text] [Related]
5. Prolonged alterations in canine striatal dopamine metabolism following subtoxic doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 4'-amino-MPTP are linked to the persistence of pyridinium metabolites. Johannessen JN; Sobotka TJ; Weise VK; Markey SP J Neurochem; 1991 Sep; 57(3):981-90. PubMed ID: 1677682 [TBL] [Abstract][Full Text] [Related]
6. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice. D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368 [TBL] [Abstract][Full Text] [Related]
7. Role of lipoamide dehydrogenase and metallothionein on 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced neurotoxicity. Dhanasekaran M; Albano CB; Pellet L; Karuppagounder SS; Uthayathas S; Suppiramaniam V; Brown-Borg H; Ebadi M Neurochem Res; 2008 Jun; 33(6):980-4. PubMed ID: 17768676 [TBL] [Abstract][Full Text] [Related]
8. Mice deficient in group IV cytosolic phospholipase A2 are resistant to MPTP neurotoxicity. Klivenyi P; Beal MF; Ferrante RJ; Andreassen OA; Wermer M; Chin MR; Bonventre JV J Neurochem; 1998 Dec; 71(6):2634-7. PubMed ID: 9832165 [TBL] [Abstract][Full Text] [Related]
9. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice. Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274 [TBL] [Abstract][Full Text] [Related]
10. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on retinal dopaminergic system in mice. Hamilton WR; Trickler WJ; Robinson BL; Paule MG; Ali SF Neurosci Lett; 2012 May; 515(2):107-10. PubMed ID: 22414866 [TBL] [Abstract][Full Text] [Related]
11. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by ethanol or acetaldehyde. Corsini GU; Zuddas A; Bonuccelli U; Schinelli S; Kopin IJ Life Sci; 1987 Mar; 40(9):827-32. PubMed ID: 2434820 [TBL] [Abstract][Full Text] [Related]
12. Increased MPTP neurotoxicity in vesicular monoamine transporter 2 heterozygote knockout mice. Gainetdinov RR; Fumagalli F; Wang YM; Jones SR; Levey AI; Miller GW; Caron MG J Neurochem; 1998 May; 70(5):1973-8. PubMed ID: 9572281 [TBL] [Abstract][Full Text] [Related]
13. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice. Leng A; Mura A; Hengerer B; Feldon J; Ferger B Behav Brain Res; 2004 Oct; 154(2):375-83. PubMed ID: 15313025 [TBL] [Abstract][Full Text] [Related]
14. Dopamine neurons from transgenic mice with a knockout of the p53 gene resist MPTP neurotoxicity. Trimmer PA; Smith TS; Jung AB; Bennett JP Neurodegeneration; 1996 Sep; 5(3):233-9. PubMed ID: 8910901 [TBL] [Abstract][Full Text] [Related]
15. Synthetic bovine proline-rich-polypeptides generate hydroxyl radicals and fail to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in mice. Knaryan VH; Samantaray S; Varghese M; Srinivasan A; Galoyan AA; Mohanakumar KP Neuropeptides; 2006 Aug; 40(4):291-8. PubMed ID: 16712929 [TBL] [Abstract][Full Text] [Related]
16. The impact of gender and estrogen on striatal dopaminergic neurotoxicity. Miller DB; Ali SF; O'Callaghan JP; Laws SC Ann N Y Acad Sci; 1998 May; 844():153-65. PubMed ID: 9668673 [TBL] [Abstract][Full Text] [Related]
17. Assessment of the role of multidrug resistance-associated proteins in MPTP neurotoxicity in mice. Plangár I; Zádori D; Szalárdy L; Vécsei L; Klivényi P Ideggyogy Sz; 2013 Nov; 66(11-12):407-14. PubMed ID: 24555241 [TBL] [Abstract][Full Text] [Related]
18. Partial protective effect of MK-801 on MPTP-induced reduction of striatal dopamine in mice. Tabatabaei A; Perry TL; Hansen S; Krieger C Neurosci Lett; 1992 Jul; 141(2):192-4. PubMed ID: 1436633 [TBL] [Abstract][Full Text] [Related]